Advertisement
(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
6 Robot Vacuum Cleaners for Easy Home Cleaning - 2Israel halts defense sales to France, citing 'hostile attitude,' sources tell 'Post'
- 3Computerized Moderation: Tracking down Equilibrium in the Advanced Age
- 4Parents speak out as 4-year-old fights button battery injury in intensive care unit
- 5Woman, 60, Is Finally Traveling the World Decades After Husband’s Death Held Her Back
- Find the Force of The ability to understand anyone on a deeper level: Improving Mindfulness and Connections
- 20-year-old who threatened German train attack remanded in custody
- Step by step instructions to Protect Your Senior Condo for Ideal Wellbeing and Solace
- Alice Wong, founder of the Disability Visibility Project, dies at 51
- 5 Home EV Chargers for Proficient and Solid Charging
- Vacuum Cleaners That Are Not difficult To Use For Home
- Fuel Price Spike Drives Surge in Used EV Sales in Europe
- Mars orbiter sees 'butterfly' crater spread its wings on the Red Planet
- Israel reports first missile fire from Yemen since start of Iran war
